Protective immunity against congenital toxoplasmosis with recombinant SAG1 protein in a guinea pig model.
about
Animal models of intellectual disability: towards a translational approachEffect of codon optimization and subcellular targeting on Toxoplasma gondii antigen SAG1 expression in tobacco leaves to use in subcutaneous and oral immunization in mice.Perinatal Listeria monocytogenes susceptibility despite preconceptual priming and maintenance of pathogen-specific CD8(+) T cells during pregnancy.DNA prime and peptide boost immunization protocol encoding the Toxoplasma gondii GRA4 induces strong protective immunity in BALB/c miceVaccination with Toxoplasma gondii SAG-1 protein is protective against congenital toxoplasmosis in BALB/c mice but not in CBA/J mice.Current status of toxoplasmosis vaccine development.Research progress on surface antigen 1 (SAG1) of Toxoplasma gondii.Molecular cloning, sequencing, and biological characterization of GRA4 gene of Toxoplasma gondii.A heterologous prime-boost vaccination regime using DNA and a vaccinia virus, both expressing GRA4, induced protective immunity against Toxoplasma gondii infection in mice.Protective effects of immunization with a recombinant cyst antigen in mouse models of infection with Toxoplasma gondii tissue cysts.Comparing the effect of IL-12 genetic adjuvant and alum non-genetic adjuvant on the efficiency of the cocktail DNA vaccine containing plasmids encoding SAG-1 and ROP-2 of Toxoplasma gondii.Targeted Delivery of Toxoplasma gondii Antigens to Dendritic Cells Promote Immunogenicity and Protective Efficiency against Toxoplasmosis.Detection of antibodies to Toxoplasma gondii in domesticated ruminants by recombinant truncated SAG2 enzyme-linked immunosorbent assay.Toxoplasma gondii: humoral and cellular immune response of BALB/c mice immunized via intranasal route with rTgROP2.
P2860
Q28389500-771A91E4-7421-4B39-A082-B51C9FE2E19CQ33633418-C48A529E-DBAE-45C5-AD25-A445AB2B06C9Q34455672-08D1689F-6304-47D0-A305-BFD62B086CE6Q35023899-3226315C-106F-45AB-B4D8-B61433E72272Q36375429-2C80C137-9B4D-4611-B0AB-D9ADFBC929EFQ37503262-D9CFC811-705D-43A8-A960-475E42169D1EQ38204033-F113FB90-BBE6-4E2A-8574-1798EC525074Q42594463-FD041576-BD5D-463D-BB5F-D33771CDC497Q45403934-8348161A-6185-47F9-BF9A-B208CF84A174Q46050882-39DE2178-8804-45E5-9EE7-5D589FC2E4DCQ51358760-09B2AD26-7697-4223-B8EF-F0C9DA711FCBQ51743228-068F749F-7F4B-4FD4-BE43-92C8003A9BBFQ53011057-12BADB93-A137-48EF-A09F-281CC2F8F2B1Q54373467-A541A943-3265-402A-905A-9060E72D9C3B
P2860
Protective immunity against congenital toxoplasmosis with recombinant SAG1 protein in a guinea pig model.
description
2000 nî lūn-bûn
@nan
2000 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Protective immunity against co ...... protein in a guinea pig model.
@ast
Protective immunity against co ...... protein in a guinea pig model.
@en
type
label
Protective immunity against co ...... protein in a guinea pig model.
@ast
Protective immunity against co ...... protein in a guinea pig model.
@en
prefLabel
Protective immunity against co ...... protein in a guinea pig model.
@ast
Protective immunity against co ...... protein in a guinea pig model.
@en
P2093
P2860
P1476
Protective immunity against co ...... protein in a guinea pig model.
@en
P2093
P2860
P304
P356
10.1128/IAI.68.9.4948-4953.2000
P407
P577
2000-09-01T00:00:00Z